IOVS | Ma, et al.
Archives: Publications
Publications
Tumor Pigmentation Does Not Affect Light-Activated Belzupacap Sarotalocan Treatment but Influences Macrophage Polarization in a Murine Melanoma Model
ARVO IOVS | Sen Ma, et al.
Immune checkpoint inhibition combined with targeted therapy using a novel virus‑like drug conjugate induces complete responses in a murine model of local and distant tumors
Harnessing Human Papillomavirus’ Natural Tropism to Target Tumors
Virus-like particle-drug conjugates induce protective, long-lasting adaptive anti-tumor immunity in the absence of specifically targeted tumor antigens
Transurethral resection of bladder tumour (TURBT)
Translational Andrology and Urology | Kim, et al.
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) – 2019 Update
European Urology | Babjuk et al.
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity
Frontiers in Oncology | Brunetti, et al.
An infrared dye-conjugated virus-like particle for the treatment of primary uveal melanoma
Molecular Cancer Therapeutics | Kines, et al.
Uveal melanoma: relatively rare but deadly cancer
Nature Eye | Kaliki. et al.